Literature DB >> 7627513

Non-operative management of breast masses diagnosed as fibroadenoma.

P J Cant1, M V Madden, M G Coleman, D M Dent.   

Abstract

A 7-9-year study was undertaken in 99 female patients (median age 20 years), 56 of whom had single and 43 multiple fibroadenomas (total 279). Thirty-four women with 58 masses (21 per cent) were lost to follow-up. Twenty-eight women with 73 masses (26 per cent) subsequently underwent excision at a median of 10 (range 3-59) months for single and 38 (1-110) months for multiple fibroadenomas (P = 0.03), with histological confirmation in 71 and other benign disease in two cases. There was resolution of 107 masses (38 per cent of those entered into the study, 72 per cent of those not lost or excised), leaving 41 persisting masses (15 per cent of those entered into the study, 28 per cent of those not lost or excised). The actuarial probability of disappearance was 0.46 at 5 years and 0.69 at 9 years (Kaplan-Meier analysis). There was no difference in the rate of resolution when 56 single lesions were compared with 223 multiple lesions, or when 192 lesions measuring 2 cm or less in diameter were compared with 87 greater than 2 cm. Resolution was significantly more frequent in women aged 20 years or less than in those who were older (P < 0.01). Non-operative management remains a safe approach in selected women and should be followed by resolution of half of fibroadenomas at 5 years.

Entities:  

Mesh:

Year:  1995        PMID: 7627513     DOI: 10.1002/bjs.1800820624

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  16 in total

Review 1.  Vacuum-assisted breast biopsy for breast cancer.

Authors:  Hai-Lin Park; Jisun Hong
Journal:  Gland Surg       Date:  2014-05

2.  Clinicopathologic profile of benign breast conditions in Indian women: prospective study based on aberrations of normal development and involution classification.

Authors:  Navneet Kaur; Nitin Agarwal; Pankaj Panwar; Kiran Mishra
Journal:  World J Surg       Date:  2012-09       Impact factor: 3.352

Review 3.  Clinician's guide to imaging and pathologic findings in benign breast disease.

Authors:  Lonzetta Neal; Cindy L Tortorelli; Aziza Nassar
Journal:  Mayo Clin Proc       Date:  2010-03       Impact factor: 7.616

4.  Is it Necessary to Excise All Breast Lesions? Experience from a University-Based Breast Unit.

Authors:  Char-Hong Ng; Taib Nur-Aishah; Cheng-Har Yip
Journal:  Malays Fam Physician       Date:  2009-08-31

Review 5.  Cryosurgery for breast fibroadenomas.

Authors:  Lizhi Niu; Binghui Wu; Kecheng Xu
Journal:  Gland Surg       Date:  2012-08

6.  Complex fibroadenoma and breast cancer risk: a Mayo Clinic Benign Breast Disease Cohort Study.

Authors:  Aziza Nassar; Daniel W Visscher; Amy C Degnim; Ryan D Frank; Robert A Vierkant; Marlene Frost; Derek C Radisky; Celine M Vachon; Ruth A Kraft; Lynn C Hartmann; Karthik Ghosh
Journal:  Breast Cancer Res Treat       Date:  2015-08-12       Impact factor: 4.872

7.  Analysis of factors predicting surgical intervention and associated costs in pediatric breast masses: a single center study.

Authors:  E Graham Englert; Guillermo Ares; Andrea Henricks; Karen Rychlik; Catherine J Hunter
Journal:  Pediatr Surg Int       Date:  2018-04-11       Impact factor: 1.827

Review 8.  Management of breast fibroadenomas.

Authors:  R Greenberg; Y Skornick; O Kaplan
Journal:  J Gen Intern Med       Date:  1998-09       Impact factor: 5.128

9.  Vacuum-assisted core-needle biopsy as a diagnostic and therapeutic method in lesions radiologically suspicious of breast fibroadenoma.

Authors:  Karol Połom; Dawid Murawa; Piotr Nowaczyk; Beata Adamczyk; Elizabeth Giles; Sonia Fertsch; Michal Michalak; Paweł Murawa
Journal:  Rep Pract Oncol Radiother       Date:  2010-12-23

10.  Frequent MED12 mutations in phyllodes tumours of the breast.

Authors:  M Yoshida; S Sekine; R Ogawa; H Yoshida; A Maeshima; Y Kanai; T Kinoshita; A Ochiai
Journal:  Br J Cancer       Date:  2015-04-02       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.